Vikas Goyal has one of the best records in biotech having spent over 8 years at SR One partnering with companies like Nimbus and Morphic Therapeutic before joining Pandion Therapeutics (acquired by Merck) full-time after investing in it as well. Now starting Trekk Venture Parners, Vikas' story uniquely blends success across investing, operations, and company building.
Starting off his career at McKinsey, Vikas went on to work with dozens of start-ups and early-stage companies as a consultant at Extera Partners then went off to earn his MBA in healthcare management from Wharton. He started work in business development at Infinity Pharmaceuticals before joining SR One full-time after an internship there during business school.
Biotech Company Building, Partnering, Investing Towards Better Medicines with Vikas Goyal